$54.00
-9.40-14.83%
Last update: Nov 12, 2:03 PM
Sol-Gel Technologies Ltd (SLGL) Stock Price, Quote, News & History
SLGLNASDAQ
Sol-Gel Technologies ends development of SGT-210 in Darier disease after Phase 1b data show no efficacy versus vehicle.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610...
You can purchase shares of Sol-Gel Technologies (NASDAQ:SLGL) through any online brokerage.
Other companies in Sol-Gel Technologies’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Sol-Gel Technologies has a consensus price target of $145.00.
The stock price for Sol-Gel Technologies (NASDAQ: SLGL) is $54 last updated November 12, 2026 at 2:03 PM EST.
There are no upcoming dividends for Sol-Gel Technologies.
Sol-Gel Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for Sol-Gel Technologies.
Sol-Gel Technologies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
